跳转至内容
Merck
CN

D9815

多沙唑嗪 甲磺酸酯

≥97% (HPLC), powder

别名:

1-(4-氨基-6,7-二甲氧基-2-喹唑啉基)-4-[4-(1,4-苯并二氧基-2-基)carpiperazin-1-基)]-6,7-二甲氧基喹唑啉 甲磺酸酯, 多沙唑嗪甲磺酸盐

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式(希尔记法):
C23H25N5O5 · CH3SO3H
化学文摘社编号:
分子量:
547.58
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352200
MDL number:
Assay:
≥97% (HPLC)
Form:
powder
Quality level:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


Quality Level

assay

≥97% (HPLC)

form

powder

color

white

SMILES string

CS(O)(=O)=O.COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4COc5ccccc5O4

InChI

1S/C23H25N5O5.CH4O3S/c1-30-18-11-14-15(12-19(18)31-2)25-23(26-21(14)24)28-9-7-27(8-10-28)22(29)20-13-32-16-5-3-4-6-17(16)33-20;1-5(2,3)4/h3-6,11-12,20H,7-10,13H2,1-2H3,(H2,24,25,26);1H3,(H,2,3,4)

InChI key

VJECBOKJABCYMF-UHFFFAOYSA-N

Biochem/physiol Actions

α1-肾上腺素能受体拮抗剂;放松前列腺平滑肌

Features and Benefits

这种化合物是神经科学研究的特色产品。点击此处发现更多特色神经科学产品。在sigma.com/discover-bsm可了解更多关于生物活性小分子的其他研究领域。


Still not finding the right product?

Explore all of our products under 多沙唑嗪 甲磺酸酯


存储类别

11 - Combustible Solids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库


商品

DISCOVER Bioactive Small Molecules for Neuroscience


Sakip Erturhan et al.
Urology, 81(3), 640-643 (2013-01-25)
To evaluate the possible efficacy of an α1 blocker (doxazosin) therapy on the management and disease course in pediatric patients with distal ureteral stones. A total of 45 patients (24 boys and 21 girls) with a single lower ureteral stone
Cédric M Hysek et al.
Psychopharmacology, 224(3), 363-376 (2012-06-16)
Pupillometry can be used to characterize autonomic drug effects. This study was conducted to determine the autonomic effects of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy), administered alone and after pretreatment with reboxetine, duloxetine, clonidine, carvedilol, and doxazosin, on pupillary function. Infrared pupillometry was
Thomas F Newton et al.
PloS one, 7(2), e30854-e30854 (2012-02-10)
Preclinical research implicates dopaminergic and noradrenergic mechanisms in mediating the reinforcing effects of drugs of abuse, including cocaine. The objective of this study was to evaluate the impact of treatment with the noradrenergic α(1) receptor antagonist doxazosin on the positive



全球贸易项目编号

货号GTIN
D9815-50MG04061833591222
D9815-250MG04061832090573